LabCompass

Tamio Okimoto

Medicine · The Ohio State University

Publications

95

Citations

918

Est. group size

~27

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Tamio Okimoto's research centers on lung cancer, particularly EGFR-mutated non-small cell lung cancer (NSCLC), and its treatment with targeted therapies like osimertinib and afatinib, along with drug resistance mechanisms. The work also spans respiratory diseases more broadly, including COPD, asthma, idiopathic pulmonary fibrosis, and pleural mesothelioma, often combining clinical case reports with imaging and biomarker studies. This research would suit students interested in clinical pulmonology, oncology drug response, and translational studies connecting molecular findings to patient care.

EGFR-mutated lung cancer treatmentDrug resistance in targeted cancer therapyImmunotherapy-related lung toxicity (checkpoint inhibitor pneumonitis)Respiratory disease diagnosis (COPD, asthma, pulmonary fibrosis)Case reports in thoracic oncology and pulmonology

Publication output has fluctuated over the past decade, with a dip around 2020 and 2024, but shows a strong resurgence in 2025-2026, suggesting renewed or increased research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.0/year recently
2017: 4 publications172018: 9 publications182019: 15 publications15192020: 3 publications202021: 6 publications212022: 6 publications222023: 5 publications232024: 2 publications242025: 15 publications15252026: 7 publications26
Recent publications
Publishes in
  • Internal Medicine×10
  • Anticancer Research×4
  • Cancer Science×3
  • Respirology Case Reports×3
  • Journal of Clinical Oncology×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile